Melatonin alleviates high glucose-induced cardiomyocyte injury through suppressing mitochondrial FUNDC1-DRP1 axis
Journal of Pharmacy and Pharmacology · 2024
DOI: 10.1093/jpp/rgae114 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmacy and Pharmacology, 2024. Verfasst von Junyi Zheng und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Tianjin Chest Hospital, Tianjin 300222, China. Hauptthemen laut MEDLINE: Myocytes, Cardiac, Melatonin, Glucose, Dynamins. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: Science and Technology Fund of the Tianjin Health commission, Tianjin Key Medical Discipline (Specialty) Construction Project.
Abstract (Originalsprache)
Objectives
To use H9c2 cardiomyocytes to establish a diabetic cardiomyopathic model by exposing these cells to high glucose (HG), followed by treating them with melatonin (MEL) or plasmid vectors overexpressing FUN14 Domain Containing 1 (FUNDC1).
Methods
We employed quantitative real-time PCR, mitochondrial staining, and biochemical assays to measure the activity of various antioxidant and mitochondrial complex functions under various treatment conditions. Key findings Our results showed that HG induced the expression of FUNDC1 and increased mitochondrial oxidative stress and fragmentation, while MEL treatment reversed most of these pathological effects. Moreover, HG exposure activated dynamin-related protein 1 expression and its translocation to mitochondria. Modulation of AMP-activated protein kinase level was found to be another pathological hallmark. In silico molecular docking, analysis revealed that MEL could directly bind the catalytic groove of FUNDC1 through Van der Waal’s force and hydrogen bonding. Finally, MEL ameliorated diabetic cardiomyopathy-induced mitochondrial injury through FUNDC1 in vivo.
Conclusions
Hyperglycemia induced mitochondrial fragmentation and altered electron transport chain complex functions, which could be ameliorated by MEL treatment, suggesting its potential as a cardiovascular therapeutic.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Tianjin Chest Hospital, Tianjin 300222, China.
- Department of Cardiology, Chest Hospital, Tianjin University, Tianjin 300222, China.
- Clinical School of Thoracic, Tianjin Medical University, Tianjin 300222, China.
- Tianjin Institute of Cardiovascular Disease, Tianjin 300222, China.
ORCID-Profile: Xukun Guo
Förderung
- Science and Technology Fund of the Tianjin Health commission
- Tianjin Key Medical Discipline (Specialty) Construction Project
Zitieren
APA
Zheng, J., Zhao, L., Zhang, Y., He, W., Guo, X., & Wang, J. (2024). Melatonin alleviates high glucose-induced cardiomyocyte injury through suppressing mitochondrial FUNDC1-DRP1 axis. Journal of Pharmacy and Pharmacology. https://doi.org/10.1093/jpp/rgae114
Vancouver
Zheng J, Zhao L, Zhang Y, He W, Guo X, Wang J. Melatonin alleviates high glucose-induced cardiomyocyte injury through suppressing mitochondrial FUNDC1-DRP1 axis. Journal of Pharmacy and Pharmacology. 2024. doi:10.1093/jpp/rgae114
BibTeX
@article{Zheng2024,
author = {Zheng, Junyi and Zhao, Lili and Zhang, Yingying and He, Wenbin and Guo, Xukun and Wang, Jixiang},
title = {Melatonin alleviates high glucose-induced cardiomyocyte injury through suppressing mitochondrial FUNDC1-DRP1 axis},
journal = {Journal of Pharmacy and Pharmacology},
year = {2024},
doi = {10.1093/jpp/rgae114}
}
EUVIMED